about
The Therapeutic Aspects of the Endocannabinoid System (ECS) for Cancer and their Development: From Nature to Laboratory.Anti-aversive effects of cannabidiol on innate fear-induced behaviors evoked by an ethological model of panic attacks based on a prey vs the wild snake Epicrates cenchria crassus confrontation paradigm.Epidermal growth factor receptor transactivation by the cannabinoid receptor (CB1) and transient receptor potential vanilloid 1 (TRPV1) induces differential responses in corneal epithelial cells.Marijuana-based drugs: innovative therapeutics or designer drugs of abuse?Cannabinoid CB₁ receptor is downregulated in clear cell renal cell carcinoma.Methods for recombinant expression and functional characterization of human cannabinoid receptor CB2.Cannabidiol as an emergent therapeutic strategy for lessening the impact of inflammation on oxidative stress.Pharmacogenetics of new analgesics.Highly selective inhibitors of monoacylglycerol lipase bearing a reactive group that is bioisosteric with endocannabinoid substrates.Traditional herbal management of sickle cell anemia: lessons from NigeriaEpigenetic Effects of Cannabis Exposure.Immunoactive effects of cannabinoids: considerations for the therapeutic use of cannabinoid receptor agonists and antagonists.Doors of deception: the diaspora of designer drugs.Rational Modification of the Biological Profile of GPCR Ligands through Combination with Other Biologically Active Moieties.Identification of a Potent and Selective Cannabinoid CB1 Receptor Antagonist from Auxarthron reticulatum.Peripheral interactions between cannabinoid and opioid systems contribute to the antinociceptive effect of crotalphine.O-hydroxyacetamide carbamates as a highly potent and selective class of endocannabinoid hydrolase inhibitors.Corneal Nerve Fiber Structure, Its Role in Corneal Function, and Its Changes in Corneal Diseases.Highly selective CB2 receptor agonist A836339 has gastroprotective effect on experimentally induced gastric ulcers in mice.ω-Imidazolyl- and ω-Tetrazolylalkylcarbamates as Inhibitors of Fatty Acid Amide Hydrolase: Biological Activity and in vitro Metabolic Stability.
P2860
Q33623423-898788BC-9729-48B1-9C43-81870FA358F9Q34028554-46C4EDB2-D45C-4DA7-BCF8-0417BBF85C09Q34079507-00985DDC-0272-4D99-9882-9B5B3C4BF2CDQ34173626-AB733DBF-C7E8-4FE6-B170-E59F6AF73424Q34338079-DDBE0F7B-5AAE-4B27-BC41-A1972E648A03Q34413054-B0553CBF-3D2B-4E4A-B5E3-1EDAAD341AA7Q34898890-3FF3202D-727C-40A0-8420-D4F458637151Q35005640-171122BD-8F2B-4F5D-A9FF-47B280B73769Q35992150-DC2B77D8-F2D9-4E94-8576-35BB03591687Q36413385-C81B7406-EDDE-4705-A7BA-0336CF3EFBEEQ36679940-192CD023-4737-46AB-BAAF-254598E61A9AQ37244823-68B5BD77-B6C7-4F06-B46F-BA4638E80C77Q37940938-41653889-6B40-4289-BCB6-5ABDD45A993FQ38458891-327F57D2-F19B-49F9-ABB0-52C866B6AE12Q39508113-0FC52D30-56F5-4D8A-9873-239CC37D5CDFQ41956563-9B404C74-ED3C-447B-9ACA-E7997FA6FB2DQ41971391-EE34AEC7-F986-4359-8520-74AEE06BC003Q45990546-6CAC800E-58DC-49F8-976A-5C8BC07F003FQ52762339-5549A835-BEED-4599-9998-1B1FAF97B18DQ52890709-370A107B-F2FA-4F0C-A7BC-48D3EF4A8ADE
P2860
description
2009 nî lūn-bûn
@nan
2009 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Cannabinoid Receptors: A brief history and what not
@ast
Cannabinoid Receptors: A brief history and what not
@en
Cannabinoid Receptors: A brief history and what not
@nl
type
label
Cannabinoid Receptors: A brief history and what not
@ast
Cannabinoid Receptors: A brief history and what not
@en
Cannabinoid Receptors: A brief history and what not
@nl
prefLabel
Cannabinoid Receptors: A brief history and what not
@ast
Cannabinoid Receptors: A brief history and what not
@en
Cannabinoid Receptors: A brief history and what not
@nl
P921
P356
P1476
Cannabinoid Receptors: A brief history and what not
@en
P2093
John Clive Ashton
P304
P356
10.2741/3288
P577
2009-01-01T00:00:00Z